Obesity took center stage on the first day of the 2026 J.P. Morgan Healthcare Conference, with industry frontrunners Eli ...

Nvidia eyes first breakout of 2026. These clues — and an innovative deal with Eli Lilly — bode well.

Illumina on Tuesday unveiled what it calls the world’s largest functional cell dictionary that, when paired with artificial ...

“The dynamics of the policy changes that have occurred in the last year-plus since the Trump administration are certainly ...

Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, ...

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...

The FDA has instructed Novo Nordisk and Eli Lilly to remove suicide risk warnings from their weight-loss medications after a ...

This week's news roundup covers updates in health policy, technology, and access to pharmaceuticals.

The path forward looks very different depending on where a company starts from and what kind of problems its leaders are ...

Silicon Valley microprocessing giant NVIDIA and pharma powerhouse Eli Lilly announced a five-year, $1 billion partnership to create a “Co-Innovation AI Lab” designed to address key challenges in AI ...

The site, which will cost about €10.0 billion ($11.7 billion) to complete, will be the third-largest of the company’s Verbund ...